[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f2vJL18DURQcFETomm1AhuGhrgtzBLfsI-st-BKOl4e0":8,"$fZk4Sudzw6aWtmlTDEn7wvmLHbLEm-ue8yPdOEopxonQ":55,"$fbORu1GTnBEeOqIpVRED118ulEH_FvYcIKiN-RIwAJXA":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67544,867180,[],"https://ystcdn.venuertc.com/medical/ystApp/dQ4Pxlwso3rc1NhluBbxmQ6HzjnaGqJP.png","王志刚","山西省汾阳医院","妇科","主治医师",23,0,"了解卵巢恶性肿瘤：第一临床分期常用药品安全用药指南","","https://cdn.yishi-tong.com/console/store-unknown/6atC9Z6hnT-TH686xipClExn5h8UFGYt.png","\u003Cdiv id=\"material_title\" class=\"ovarian-guide-title\">\n了解卵巢恶性肿瘤：第一临床分期常用药品安全用药指南\n\u003C/div>\n\n\u003Cdiv class=\"ovarian-guide-section bg-light-section\">\n\u003Ch2 class=\"ovarian-section-heading\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 开场：卵巢恶性肿瘤第一期常用药品怎么用？\u003C/h2>\n\u003Cp class=\"ovarian-paragraph\">\n在临床分期为第一期的卵巢恶性肿瘤治疗中，化疗药物、免疫抑制剂以及靶向治疗药物都可能会用到。这些药品不仅种类多，每种的服用方式、时间、相互作用和注意事项也很有讲究。今天这份指南，就带你了解常见药品的7大关键用药细节，每一点都很实用，尤其适用于需长期治疗和多药联用的患者及家属。\n\u003C/p>\n\u003C/div>\n\n\u003C!-- 02 药品成分与剂型一览 -->\n\u003Cdiv class=\"ovarian-guide-section bg-gradient-section\">\n\u003Ch2 class=\"ovarian-section-heading\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 药品成分与剂型选择\u003C/h2>\n\u003Cp class=\"ovarian-paragraph\">\n当前卵巢恶性肿瘤第一期治疗常见药品主要包括：铂类化疗药物（如卡铂、顺铂）、紫杉烷类药物（如紫杉醇），以及部分靶向药物（如贝伐珠单抗）。此外，根据个人状况可能用到免疫制剂或辅助支持药物。\n\u003C/p>\n\u003Cul class=\"ovarian-list\">\n\u003Cli>\u003Cspan class=\"ovarian-list-item-head\">化疗药物：\u003C/span>大多采用注射剂型，偶有口服制剂；卡铂、紫杉醇常以静脉输注，每次用药时间在几十分钟至数小时不等。\u003C/li>\n\u003Cli>\u003Cspan class=\"ovarian-list-item-head\">靶向药物：\u003C/span>贝伐珠单抗等多为注射剂型，部分新型靶向药如PARP抑制剂（奥拉帕利）为口服片剂。\u003C/li>\n\u003Cli>\u003Cspan class=\"ovarian-list-item-head\">辅助药物：\u003C/span>用于预防恶心、保护胃黏膜、支持骨髓，如地塞米松、奥美拉唑、升白药物。\u003C/li>\n\u003C/ul>\n\u003Cp class=\"ovarian-paragraph\">正确做法：用药前务必确认药品名称、有效期、剂型、规格，避免混淆。\u003C/p>\n\u003C/div>\n\n\u003C!-- 03 药品作用机制简述 -->\n\u003Cdiv class=\"ovarian-guide-section bg-cloud-section\">\n\u003Ch2 class=\"ovarian-section-heading\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 药品作用机制简析\u003C/h2>\n\u003Cp class=\"ovarian-paragraph\">\n不同药品治疗作用各异：\u003Cbr>\n\u003Cspan class=\"ovarian-list-item-head\">① 铂类化疗药（卡铂、顺铂）\u003C/span>通过破坏肿瘤细胞DNA来达到杀灭作用。\u003Cbr>\n\u003Cspan class=\"ovarian-list-item-head\">② 紫杉醇\u003C/span>干扰细胞分裂过程，让肿瘤细胞无法增殖。\u003Cbr>\n\u003Cspan class=\"ovarian-list-item-head\">③ 靶向药物（贝伐珠单抗）\u003C/span>阻断肿瘤血管生成，使肿瘤“断粮”，影响生长。\u003Cbr>\n\u003Cspan class=\"ovarian-list-item-head\">④ PARP抑制剂（奥拉帕利等）\u003C/span>选择性阻断肿瘤细胞的修复通路，提升肿瘤敏感性。\u003Cbr>\n这些药品大多只作用于快速分裂的细胞，所以对正常骨髓、毛囊等组织也可能产生影响。\n\u003C/p>\n\u003C/div>\n\n\u003C!-- 04 服用时间与用法技巧 -->\n\u003Cdiv class=\"ovarian-guide-section bg-beige-section\">\n\u003Ch2 class=\"ovarian-section-heading\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 服用时间与用法技巧 🕰️\u003C/h2>\n\u003Cul class=\"ovarian-list\">\n\u003Cli>\n\u003Cstrong>化疗药物（静脉注射）：\u003C/strong>治疗需在医院由专业医护操作，常规每3-4周一次，疗程具体视医生安排。\u003Cbr>\n正确做法：治疗当天宜清淡饮食，注射后观察30分钟。\n\u003C/li>\n\u003Cli>\n\u003Cstrong>口服药（奥拉帕利等PARP抑制剂）：\u003C/strong>推荐早晚各一次，固定间隔12小时。\u003Cbr>\n正确做法：服用时坚持用清水吞服，不要研碎或嚼服，也勿与柚子汁同服。\n\u003C/li>\n\u003Cli>\n\u003Cstrong>辅助药物（如奥美拉唑）：\u003C/strong>通常于餐前服用，若需多药同服，请严格遵医嘱分时段服用。\n\u003C/li>\n\u003C/ul>\n\u003Cp class=\"ovarian-paragraph\">\n需要注意：如临时漏服口服药，若距离下一次服药还超过8小时，可以立即补服；如已接近下次服药，直接略过，不要加倍服药。\n\u003C/p>\n\u003C/div>\n\n\u003C!-- 05 药物相互作用 -->\n\u003Cdiv class=\"ovarian-guide-section bg-mint-section\">\n\u003Ch2 class=\"ovarian-section-heading\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 药物相互作用 🤝\u003C/h2>\n\u003Cp class=\"ovarian-paragraph\">\n卵巢恶性肿瘤治疗常常联合用药，有几种典型相互作用值得关注：\n\u003C/p>\n\u003Cul class=\"ovarian-list\">\n\u003Cli>\u003Cspan class=\"ovarian-list-item-head\">铂类化疗药\u003C/span>不宜与氨基糖苷类抗生素长期合用，否则肾毒性风险增加。\u003Cbr>正确做法：用药期间要定期监测肾功能。\u003C/li>\n\u003Cli>\u003Cspan class=\"ovarian-list-item-head\">紫杉类药物\u003C/span>与某些免疫抑制剂同用时有增加骨髓抑制风险。\u003Cbr>正确做法：疗程中应常规查血象。\u003C/li>\n\u003Cli>\u003Cspan class=\"ovarian-list-item-head\">口服靶向药\u003C/span>（如奥拉帕利）与抗酸药物同服可能降低吸收，应错开2小时以上。\u003C/li>\n\u003Cli>柚子及柚子制品会影响多种口服药代谢，应避免。\u003C/li>\n\u003C/ul>\n\u003Cp class=\"ovarian-paragraph\">\n特别提醒：如需服用降糖药、降压药等慢性病药物，应复核是否有药物相互作用，再做调整。\n\u003C/p>\n\u003C/div>\n\n\u003C!-- 06 特殊人群用药调整 -->\n\u003Cdiv class=\"ovarian-guide-section bg-rose-section\">\n\u003Ch2 class=\"ovarian-section-heading\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 特殊人群用药调整 👨‍👩‍👧‍👦\u003C/h2>\n\u003Cul class=\"ovarian-list\">\n\u003Cli>\n\u003Cstrong>老年患者：\u003C/strong>代谢慢，化疗及靶向药剂量常须下调，疗程前后重点查肾功能与血象。\n\u003C/li>\n\u003Cli>\n\u003Cstrong>肝肾功能不全：\u003C/strong>部分药物（尤其铂类）排泄依赖肾脏，如有受损应减少单次用量或延长间隔。\n\u003C/li>\n\u003Cli>\n\u003Cstrong>孕妇及哺乳期：\u003C/strong>绝大多数化疗、靶向药物说明书均明确禁用。\n\u003C/li>\n\u003Cli>\n\u003Cstrong>糖尿病、高血压等慢性病患者：\u003C/strong>应提前报告全部服药情况，协同医生评估用药安全。如例案中的56岁女性，需同时调整降糖药用量，注意监测血糖和血压。\n\u003C/li>\n\u003C/ul>\n\u003C/div>\n\n\u003C!-- 07 常见不良反应 -->\n\u003Cdiv class=\"ovarian-guide-section bg-sky-section\">\n\u003Ch2 class=\"ovarian-section-heading\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 常见不良反应及处理方法 ⚠️\u003C/h2>\n\u003Cul class=\"ovarian-list\">\n\u003Cli>\n\u003Cstrong>骨髓抑制：\u003C/strong>化疗、部分靶向药常见副作用。表现为白细胞、血小板下降。\u003Cbr>正确做法：出现骨髓抑制时，应遵医嘱暂停或减少用药，视情况加用升白药物或输注血小板。\n\u003C/li>\n\u003Cli>\n\u003Cstrong>胃肠道反应：\u003C/strong>如恶心、呕吐，主要在化疗期间出现。\u003Cbr>正确做法：可提前使用止吐药，如昂丹司琼、多稀水等，坚持少食多餐。\n\u003C/li>\n\u003Cli>\n\u003Cstrong>过敏反应：\u003C/strong>紫杉醇等可能导致过敏。\u003Cbr>正确做法：首次用药需留观，若皮肤瘙痒、胸闷、呼吸困难须迅速告知医护。\n\u003C/li>\n\u003Cli>\n\u003Cstrong>脱发：\u003C/strong>常见且多可逆，不影响疗效。\u003C/li>\n\u003Cli>\n\u003Cstrong>肾功能损伤：\u003C/strong>主要为铂类药物副作用。\u003Cbr>正确做法：用药期间多饮水，定期查肾功能。\n\u003C/li>\n\u003C/ul>\n\u003Cp class=\"ovarian-paragraph\">\n出现持续高热、腹泻不止或明显乏力时，要及时与医生联系，不要自行停药或加药。\n\u003C/p>\n\u003C/div>\n\n\u003C!-- 08 药品储存与有效期 -->\n\u003Cdiv class=\"ovarian-guide-section bg-lemon-section\">\n\u003Ch2 class=\"ovarian-section-heading\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 药品储存方法与过期处理 🗄️\u003C/h2>\n\u003Cul class=\"ovarian-list\">\n\u003Cli>\n\u003Cstrong>注射药物：\u003C/strong>医院储存于冷藏或室温内，患者无需自行保存，仅注意注射当天药品外观是否异常、标签完整。\u003C/li>\n\u003Cli>\n\u003Cstrong>口服药品：\u003C/strong>建议储存在干燥、避光、常温处。部分说明书注明“密封，低于25℃”或“低于30℃”存放，不要放在浴室、厨房或冰箱冷冻室。\u003C/li>\n\u003Cli>\n\u003Cstrong>所有药品：\u003C/strong>开封后如超半年未服，应弃置不用。过期药品不要自行丢入垃圾桶，应交医药回收点处理。\u003C/li>\n\u003C/ul>\n\u003C/div>\n\n\u003C!-- 09 漏服、过量及应急处理 -->\n\u003Cdiv class=\"ovarian-guide-section bg-lilac-section\">\n\u003Ch2 class=\"ovarian-section-heading\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 漏服、过量与紧急处理 🚨\u003C/h2>\n\u003Cul class=\"ovarian-list\">\n\u003Cli>\n\u003Cstrong>漏服：\u003C/strong>口服药如奥拉帕利补服需遵循说明书（建议8小时内补服，超过则略过）。\u003C/li>\n\u003Cli>\n\u003Cstrong>过量：\u003C/strong>发生过量服用要立即记录时间、用量，并联系医生。极少数情况下，可能需入院处理。\u003C/li>\n\u003Cli>\n\u003Cstrong>注射药不宜自行调整剂量或补打。\u003C/strong>\n\u003C/li>\n\u003C/ul>\n\u003Cp class=\"ovarian-paragraph\">\n正确做法：遇到任何疑似用药异常，先保持镇静，及时告知医生或药师，切勿自行改药或断药。\n\u003C/p>\n\u003C/div>\n\n\u003C!-- 10 临床案例分享 -->\n\u003Cdiv class=\"ovarian-guide-section bg-peach-section\">\n\u003Ch2 class=\"ovarian-section-heading\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 临床用药经验分享 📖\u003C/h2>\n\u003Cul class=\"ovarian-list\">\n\u003Cli>\n一位56岁女性（合并高血压、糖尿病），使用卡铂、紫杉醇联合化疗，并调整降糖与降压药用量，未出现严重不良反应，期间多次血象监测，有效预防骨髓抑制。\n\u003C/li>\n\u003Cli>\n临床上有患者口服奥拉帕利与抗酸药物同服后，药效降低，后改为错开2小时服药，达最佳疗效。\u003C/li>\n\u003Cli>\n有医护发现患者静脉化疗期间多饮水、按时查肾功能，肾损伤风险显著减少。\u003C/li>\n\u003C/ul>\n\u003C/div>\n\n\u003C!-- 11 关键数据与文献支持 -->\n\u003Cdiv class=\"ovarian-guide-section bg-moss-section\">\n\u003Ch2 class=\"ovarian-section-heading\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">11 关键药品数据与权威文献 📊\u003C/h2>\n\u003Cp class=\"ovarian-paragraph\">\n临床数据表明，卡铂+紫杉醇联合方案在第一临床分期中的客观缓解率可达70%以上\u003Csup>[1]\u003C/sup>，骨髓抑制发生率为30%-45%；奥拉帕利作为辅助治疗药，不良反应以贫血、恶心为主，发生率15%-20%\u003Csup>[2]\u003C/sup>。\n\u003C/p>\n\u003Cp class=\"ovarian-paragraph\">\n文献引用：\u003Cbr>\n\u003Cem>\n[1] Bookman, M.A. et al. (2009). \"Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: A systematic review.\" J Clin Oncol, 27(18), 3085-3093.\u003Cbr>\n[2] Ledermann, J. et al. (2014). \"Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer.\" N Engl J Med, 366(15), 1382-1392.\u003C/em>\u003C/p>\u003C/div>\n\n\u003C!-- 独立全局样式 -->\n\u003Cstyle>\n.ovarian-guide-title {\n  font-size: 40px;\n  font-weight: bold;\n  color: #3c3f52;\n  letter-spacing: 2px;\n  margin-top: 30px;\n  margin-bottom: 36px;\n  text-align: center;\n  background: linear-gradient(90deg,#e8eef5 10%,#d8f1ea 90%);\n  border-radius: 18px;\n  padding: 28px 0;\n  box-shadow: 0 2px 16px rgba(72,77,98,0.07);\n}\n\n.ovarian-section-heading {\n  font-size: 31px;\n  font-weight: 600;\n  color: #27615e;\n  background: rgba(245,246,255,0.85);\n  border-radius: 14px;\n  padding: 20px 32px;\n  margin-bottom: 18px;\n  letter-spacing: 1px;\n  box-shadow: 0 2px 8px rgba(110,148,105,0.09);\n}\n\n.ovarian-paragraph {\n  font-size: 20px;\n  color: #293a40;\n  line-height: 2;\n  margin-bottom: 18px;\n  padding: 0 10px;\n}\n\n.ovarian-list {\n  font-size: 20px;\n  color: #313f49;\n  line-height: 2.18;\n  padding-left: 18px;\n  margin-bottom: 16px;\n}\n\n.ovarian-list-item-head {\n  font-weight: 600;\n  color: #468c7b;\n  font-family: 'Arial', sans-serif;\n  margin-right: 4px;\n}\n\n.ovarian-guide-section {\n  margin-top: 38px;\n  margin-bottom: 46px;\n  border-radius: 22px;\n  padding: 36px 32px;\n  box-shadow: 0 2px 24px rgba(87,106,100,0.04);\n}\n\n.bg-light-section {\n  background: linear-gradient(90deg,#f2f7fa 0%,#f7f9fc 100%);\n}\n\n.bg-gradient-section {\n  background: linear-gradient(94deg,#eef7f3 20%,#fcece6 100%);\n}\n\n.bg-cloud-section {\n  background: linear-gradient(85deg,#f2f8fa 54%, #f9eee1 102%);\n}\n\n.bg-beige-section {\n  background: linear-gradient(110deg,#f6f5ef 25%,#f3ede2 84%);\n}\n\n.bg-mint-section {\n  background: linear-gradient(91deg,#e5f8ea 5%,#f7fefe 99%);\n}\n\n.bg-rose-section {\n  background: linear-gradient(90deg,#f2e4e7 10%, #fae9f2 94%);\n}\n\n.bg-sky-section {\n  background: linear-gradient(83deg,#e4f3fa 12%, #eff9f8 95%);\n}\n\n.bg-lemon-section {\n  background: linear-gradient(89deg,#f7f9ea 4%,#f6f5ee 97%);\n}\n\n.bg-lilac-section {\n  background: linear-gradient(95deg,#f2f0fd 21%, #eef0f7 90%);\n}\n\n.bg-peach-section {\n  background: linear-gradient(99deg,#ffe6d6 24%, #fdeeee 86%);\n}\n\n.bg-moss-section {\n  background: linear-gradient(83deg,#e8f7ed 9%, #f4faea 100%);\n}\n\n.bg-cotton-section {\n  background: linear-gradient(119deg,#fafbfc 36%, #fef6e9 92%);\n}\n\nsup {\n  font-size: 14px;\n  color: #7eaeb3;\n}\n\n@media screen and (max-width: 600px) {\n  .ovarian-guide-title { font-size:24px; padding:16px 0;}\n  .ovarian-section-heading { font-size:19px; padding:12px 16px;}\n  .ovarian-guide-section { padding:16px 8px;}\n  .ovarian-paragraph,.ovarian-list { font-size:15px;}\n}\n\u003C/style>\n\n","\u003Cdiv id=\"material_title\" class=\"ovarian-guide-title\">\n了解卵巢恶性肿瘤：第一临床分期常用药品安全用药指南\n\u003C/div>\n\n\u003Cdiv class=\"",513,"2025-10-09 11:31:28","卵巢恶性肿瘤,化疗药物,靶向治疗,药物相互作用,药品用法","本文提供卵巢恶性肿瘤第一期治疗的药品使用指南，包括化疗、免疫和靶向药物的安全用法，助您掌握治疗关键，确保用药安全。","2025-10-13 11:30:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]